Bronchiolitis Obliterans Overview

Save information for later
Sign Up

Learn About Bronchiolitis Obliterans

What is the definition of Bronchiolitis Obliterans?
Bronchiolitis obliterans is an inflammatory condition that affects the lung's tiniest airways, the bronchioles. In affected people, the bronchioles may become damaged and inflamed leading to extensive scarring that blocks the airways. Symptoms of the condition include a dry cough; shortness of breath; and/or fatigue and wheezing in the absence of a cold or asthma. Many different chemicals (such as nitrogen oxides, ammonia, welding fumes or food flavoring fumes) and respiratory infections can cause lung injury that leads to Bronchiolitis obliterans. It can also be associated with rheumatoid arthritis and graft-versus-host disease following a lung or hematopoietic cell transplantation. Another similarly named disease, Bronchiolitis obliterans organizing pneumonia, is a different disease.
What are the alternative names for Bronchiolitis Obliterans?
  • Bronchiolitis obliterans
  • Obliterative bronchiolitis
Who are the top Bronchiolitis Obliterans Local Doctors?
Geert M. Verleden
Elite in Bronchiolitis Obliterans
Geert M. Verleden
Elite in Bronchiolitis Obliterans
Geert M. Verleden

KU Leuven

Leuven, VLG, BE 

Geert Verleden practices in Leuven, Belgium. Verleden is rated as an Elite expert by MediFind in the treatment of Bronchiolitis Obliterans. Their top areas of expertise are Bronchiolitis Obliterans, Bronchitis, Hypersensitivity Pneumonitis, Lung Transplant, and Heart Transplant.

Sandra J. Hodge
Elite in Bronchiolitis Obliterans
Sandra J. Hodge
Elite in Bronchiolitis Obliterans
Sandra J. Hodge
4 North Terrace, 
Adelaide, SA, AU 

Sandra Hodge practices in Adelaide, Australia. Ms. Hodge is rated as an Elite expert by MediFind in the treatment of Bronchiolitis Obliterans. Her top areas of expertise are Bronchiolitis Obliterans, Chronic Obstructive Pulmonary Disease (COPD), Bronchitis, Lung Transplant, and Percutaneous Coronary Intervention (PCI).

 
 
 
 
Learn about our expert tiers
Learn More
Tobias Welte
Elite in Bronchiolitis Obliterans
Tobias Welte
Elite in Bronchiolitis Obliterans
Tobias Welte
Carl Neuberg Str. 1, 
Hannover, NI, DE 

Tobias Welte practices in Hannover, Germany. Mr. Welte is rated as an Elite expert by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Lung Transplant, and Endoscopy.

View All Doctors
What are the latest Bronchiolitis Obliterans Clinical Trials?
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Enrollment Status: Recruiting
Publish Date: October 07, 2025
Intervention Type: Device

Summary: This study is designed to measure the correlation of hyperpolarized 129-Xe magnetic resonance imaging (129-XeMRI) in allogeneic hematopoietic cell transplant (allo-HCT) recipients at MD Anderson Cancer Center (MDACC) who develop bronchiolitis obliterans syndrome (BOS) or BOS stage 0p (pulmonary impairment not meeting the definition for BOS, defined below) and controls with chronic graft-versus-hos...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Predicting the Quality of Response to Specific Treatments (PQRST)
Predicting the Quality of Response to Specific Treatments (PQRST)
Enrollment Status: Recruiting
Publish Date: September 18, 2025
Intervention Type: Other, Procedure

Summary: This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center